ECO Animal Health Group plc (EAH.L)

GBp 71.0

(1.43%)

Market Cap (In GBp)

48.1 Million

Revenue (In GBp)

89.42 Million

Net Income (In GBp)

1.04 Million

Avg. Volume

83.86 Thousand

Currency
GBp
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
60.0-135.0
PE
-
EPS
-
Beta Value
0.03
ISIN
GB0032036807
CUSIP
G3039F108
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. David Charles Hallas
Employee Count
-
Website
https://www.ecoanimalhealthgroupplc.com
Ipo Date
1995-09-26
Details
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is headquartered in New Malden, the United Kingdom.